EQL PHARMA AB |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 56.4 SEK | -0.35% |
|
-5.05% | +68.86% |
| 1 week | -5.05% | ||
| Current month | +0.71% |
| Sales 2025 * | 429M 40.38M 3.11B | Sales 2026 * | 490M 46.18M 3.56B | Capitalization | 1.65B 155M 11.96B |
|---|---|---|---|---|---|
| Net income 2025 * | 71M 6.69M 516M | Net income 2026 * | 89M 8.39M 647M | EV / Sales 2025 * | 3.98 x |
| Net Debt 2025 * | 59.02M 5.56M 429M | Net Debt 2026 * | 33M 3.11M 240M | EV / Sales 2026 * | 3.42 x |
| P/E ratio 2025 * |
23
x | P/E ratio 2026 * |
18.4
x | Employees | 21 |
| Yield 2025 * |
-
| Yield 2026 * |
-
| Free-Float | 100% |
More Fundamentals
* Assessed data
| 1 day | -0.35% | ||
| 1 week | -5.05% | ||
| Current month | +0.71% | ||
| 1 month | +13.94% | ||
| 3 months | +31.16% | ||
| 6 months | +63.48% | ||
| Current year | +68.86% |
1 week
54.00
60.00
1 month
49.5062.00
Current year
33.0062.00
1 year
24.7062.00
3 years
23.0062.00
5 years
9.5062.00
10 years
2.8062.00
| Date | Price | Change | Volume |
|---|---|---|---|
| 16/07/24 | 56.4 | -0.35% | 2 741 |
| 15/07/24 | 56.6 | +0.71% | 6,777 |
| 12/07/24 | 56.2 | -1.75% | 17,905 |
| 11/07/24 | 57.2 | -2.39% | 16,097 |
| 10/07/24 | 58.6 | -1.35% | 8,724 |
Delayed Quote Nasdaq Stockholm, July 16, 2024 at 11:50 am
More quotes
EQL Pharma AB is a Sweden-based Company that operates as a generic drugs and specialty pharmaceutical company. The Company engages in marketing, distributing, and selling generic drugs and specialty pharmaceuticals. Its main products are Anastrozol, Venlafaxin, Carvedilol, Metformin, Sumatriptan, Mometason, Glepark, among others. The company operates in Sweden and in Scandinavia.
Sector
Drug Retailers
Calendar
12/08/2024
- Q1 2025 Earnings Release (Projected)
Trading Rating
Investor Rating
ESG Refinitiv
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +68.86% | 155M | |
| -55.19% | 10.1B | |
| -46.55% | 8.81B | |
| -25.71% | 6.65B | |
| -4.16% | 6.45B | |
| +97.00% | 5.35B | |
| -2.92% | 4.63B | |
| +8.08% | 4.6B | |
| -32.12% | 3.79B | |
| +7.37% | 3.13B |
- Stock Market
- Equities
- EQL Stock
